250 related articles for article (PubMed ID: 32094130)
1.
Dubois J; Dubois M; Martel JF
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094130
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of omadacycline in the treatment of
Wang Y; Yi SM; Huang SM; Xu WX; Wei YW; Qu Q; Qu J
Front Cell Infect Microbiol; 2024; 14():1380312. PubMed ID: 38836055
[No Abstract] [Full Text] [Related]
3. Severe Pneumonia Caused by Legionella pneumophila: Differential Diagnosis and Therapeutic Considerations.
Chahin A; Opal SM
Infect Dis Clin North Am; 2017 Mar; 31(1):111-121. PubMed ID: 28159171
[TBL] [Abstract][Full Text] [Related]
4. Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila.
Tan JS; File TM; DiPersio JR; DiPersio LP; Hamor R; Saravolatz LD; Stout JE
Clin Infect Dis; 2001 Jun; 32(11):1562-6. PubMed ID: 11340527
[TBL] [Abstract][Full Text] [Related]
5. Treatment strategies for Legionella infection.
Pedro-Botet ML; Yu VL
Expert Opin Pharmacother; 2009 May; 10(7):1109-21. PubMed ID: 19405787
[TBL] [Abstract][Full Text] [Related]
6. Distribution of Legionella species and serogroups in patients with culture-confirmed Legionella pneumonia.
Miyashita N; Higa F; Aoki Y; Kikuchi T; Seki M; Tateda K; Maki N; Uchino K; Ogasawara K; Kiyota H; Watanabe A
J Infect Chemother; 2020 May; 26(5):411-417. PubMed ID: 32081644
[TBL] [Abstract][Full Text] [Related]
7. In vitro and intracellular activities of peptide deformylase inhibitor GSK1322322 against Legionella pneumophila isolates.
Dubois J; Dubois M; Martel JF; Aubart K; Butler D
Antimicrob Agents Chemother; 2015 Jan; 59(1):707-10. PubMed ID: 25348534
[TBL] [Abstract][Full Text] [Related]
8. A case of pneumonia caused by Legionella pneumophila serogroup 12 and treated successfully with imipenem.
Nishizuka M; Suzuki H; Ara T; Watanabe M; Morita M; Sato C; Tsuchida F; Seto J; Amemura-Maekawa J; Kura F; Takeda H
J Infect Chemother; 2014 Jun; 20(6):390-3. PubMed ID: 24629522
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of macrolides against intracellular Legionella pneumophila.
Segreti J; Meyer P; Kapell K
Diagn Microbiol Infect Dis; 1996 Jul; 25(3):123-6. PubMed ID: 8902407
[TBL] [Abstract][Full Text] [Related]
10. Severe community-acquired pneumonia due to Legionella pneumophila Serogroup 6.
Chen CY; Chen KY; Hsueh PR; Yang PC
J Formos Med Assoc; 2006 Mar; 105(3):256-62. PubMed ID: 16520845
[TBL] [Abstract][Full Text] [Related]
11. Omadacycline use in a traveler with severe Legionella pneumonia.
Wang J; Tong J; Wang Y; Chen Y
Travel Med Infect Dis; 2023; 56():102654. PubMed ID: 37858711
[No Abstract] [Full Text] [Related]
12. Efficacy of telithromycin in community-acquired pneumonia caused by Legionella pneumophila.
Carbon C; Nusrat R
Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):650-2. PubMed ID: 15322940
[No Abstract] [Full Text] [Related]
13. Legionella pneumonia: the spectrum continues to expand.
Brown RB
Chest; 2004 Jun; 125(6):1979-80. PubMed ID: 15189909
[No Abstract] [Full Text] [Related]
14. Antibiotic Resistance and Azithromycin Resistance Mechanism of Legionella pneumophila Serogroup 1 in China.
Jia X; Ren H; Nie X; Li Y; Li J; Qin T
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405864
[TBL] [Abstract][Full Text] [Related]
15. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
Bartlett JG
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic Resistance of
Pappa O; Chochlakis D; Sandalakis V; Dioli C; Psaroulaki A; Mavridou A
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32796666
[TBL] [Abstract][Full Text] [Related]
17. A Case of Community-Acquired Pneumonia Due to Legionella pneumophila Serogroup 9 Wherein Initial Treatment with Single-Dose Oral Azithromycin Appeared Useful.
Ito A; Ishida T; Tachibana H; Ito Y; Takaiwa T; Fujii H; Hashimoto T; Nakajima H; Amemura-Maekawa J
Jpn J Infect Dis; 2017 Nov; 70(6):660-662. PubMed ID: 28890505
[TBL] [Abstract][Full Text] [Related]
18. Speculations on the influence of infecting phenotype on virulence and antibiotic susceptibility of Legionella pneumophila.
Barker J; Brown MR
J Antimicrob Chemother; 1995 Jul; 36(1):7-21. PubMed ID: 8537286
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.
Edelstein PH; Edelstein MA; Lehr KH; Ren J
J Antimicrob Chemother; 1996 Jan; 37(1):117-26. PubMed ID: 8647752
[TBL] [Abstract][Full Text] [Related]
20. Legionella pneumophila serogroup 3 infection: importance of serology.
Khanna N; Meikle A; Gillespie L; Edwards G; Lindsay D
Scott Med J; 2012 Aug; 57(3):182. PubMed ID: 22859812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
